Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.3B | 2.4B | 2.0B | 2.2B |
Cost of revenue | 1.1B | 1.2B | 986.5M | 1.0B |
Gross profit | 1.2B | 1.2B | 1.0B | 1.1B |
Operating expense | ||||
Research & development | 104M | 115.3M | 93.8M | 99.8M |
Selling general and admin | 611.6M | 613.4M | 528.1M | 576.8M |
Other operating expenses | 44.2M | 38M | 32.1M | 37.4M |
Operating income | 434.2M | 453M | 378.2M | 424M |
Non operating interest income | ||||
Income | 17.6M | 24M | 18.9M | 31.1M |
Expense | 37.9M | 43.3M | 38.8M | 37.4M |
Other income expense | — | — | — | — |
Pretax income | 408.8M | 436.2M | 350.6M | 418M |
Tax provision | 114.5M | 101.2M | 94.4M | 116.4M |
Net income | 294.3M | 335M | 256.2M | 301.6M |
Basic EPS | 1.1 | — | — | — |
Diluted EPS | 1.1 | — | — | — |
Basic average shares | 262.1M | — | — | — |
Diluted average shares | 264.0M | — | — | — |
EBITDA | 540.6M | 596.8M | 475M | 548.6M |
Net income from continuing op. | 294.3M | 335M | 256.2M | 301.6M |
Minority interests | -1M | -2.3M | -100K | 100K |
Preferred stock dividends | 0 | 0 | 0 | 0 |